Moreover, Di Gennaro et al. [30] demonstrated that ECT in melanoma patients reduced regulatory T cells (Tregs) and increased CD8+ T cells, indicating that ECT promotes a favorable immune environment for tumor clearance and could be effectively combined with immunotherapies to achieve durable responses. Here, CD8A is linked to melanoma.